Cross C E, Collins H L, Bancroft G J
Clinical Sciences, London School of Hygiene and Tropical Medicine, UK.
Immunology. 1997 Jun;91(2):289-96. doi: 10.1046/j.1365-2567.1997.00238.x.
Phagocytosis is a fundamental process in innate resistance to infection. We have used the pathogenic yeast Cryptococcus neoformans to study the interaction of this encapsulated organism with murine macrophages in vitro. In the absence of exogenous opsonins the encapsulated yeast is almost totally resistant to ingestion by murine macrophages. Owing to its ability to activate the alternative complement pathway, the anti-phagocytic properties of the polysaccharide capsule can be partially overcome following opsonization in vitro with non-immune mouse serum and subsequent phagocytosis via complement receptors. Here, we demonstrate the importance of the complement receptor type 3 (CR3) in in vitro phagocytosis of the yeast and in in vivo resistance to infection. In vitro, 70% of a population of resident murine macrophages are able to ingest C. neoformans and then only inefficiently (1-2 organisms per cell). Previously we have shown that tumour necrosis factor-alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF) efficiently enhance ingestion of serum-opsonized encapsulated C. neoformans, and we now show that the cytokines convert a population of resident macrophages to a state where all the cells are competent for ingestion of large numbers of yeasts (6-8 per cell). We also show that these cytokines have a direct effect on CR3, as enhanced levels of complement-opsonized sheep red blood cells (EIgMC) bind to macrophages activated in this way. However, cytokines that have previously been shown to enhance phagocytosis of EIgMC have no effect on ingestion of encapsulated C. neoformans. These results demonstrate that the cytokines regulating CR3-dependent ingestion of C. neoformans are different to those regulating ingestion of EIgMC and reinforce the importance of studying pathogens rather than inert ligands in understanding the regulation of phagocytosis.
吞噬作用是机体天然抗感染免疫的一个基本过程。我们利用致病性酵母新型隐球菌来研究这种有荚膜的微生物与小鼠巨噬细胞在体外的相互作用。在没有外源性调理素的情况下,有荚膜的酵母几乎完全抵抗小鼠巨噬细胞的吞噬。由于其激活替代补体途径的能力,在用非免疫小鼠血清体外调理后,多糖荚膜的抗吞噬特性可被部分克服,随后通过补体受体进行吞噬。在此,我们证明了3型补体受体(CR3)在酵母体外吞噬作用及体内抗感染中的重要性。在体外,70%的驻留小鼠巨噬细胞群体能够吞噬新型隐球菌,但效率很低(每个细胞吞噬1 - 2个菌体)。此前我们已经表明,肿瘤坏死因子-α(TNF-α)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)能有效增强血清调理的有荚膜新型隐球菌的吞噬作用,现在我们发现这些细胞因子可将驻留巨噬细胞群体转变为所有细胞都能大量吞噬酵母(每个细胞吞噬6 - 8个)的状态。我们还表明,这些细胞因子对CR3有直接作用,因为补体调理的羊红细胞(EIgMC)增强的结合水平能与以这种方式激活的巨噬细胞结合。然而,先前已证明能增强EIgMC吞噬作用的细胞因子对有荚膜新型隐球菌的吞噬没有影响。这些结果表明,调节新型隐球菌CR3依赖性吞噬作用的细胞因子与调节EIgMC吞噬作用的细胞因子不同,这进一步强调了在理解吞噬作用调节机制时研究病原体而非惰性配体的重要性。